CLINICAL UPDATES · SEASON 1 · EPISODE 2

Hyperkalemia in Chronic Kidney Disease

High blood potassium — hyperkalemia — is one of the most consequential electrolyte problems in chronic kidney disease, because it can disturb the heart's rhythm without warning symptoms. This Clinical Update covers why potassium accumulates as kidney function declines, how monitoring is structured, and the layered strategies — diet, medication review, and modern potassium binders — used to keep levels safe while preserving beneficial kidney and heart medicines.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

MedicalVideos Clinical Updates is an educational series produced with full editorial independence. If an episode is sponsor-funded, that funding is labelled on the episode page and on the series hub.

In short: Failing kidneys excrete less potassium, and common kidney-protective medicines raise it further. Management combines regular monitoring, dietary counselling, correcting acidosis, reviewing culprit drugs, and — when needed — potassium binders that allow protective medicines to continue.

The update

The clinical picture

The kidneys handle almost all of the body's potassium excretion, adjusting output to match intake. In CKD that flexibility shrinks, so potassium balance depends increasingly on the colon, on insulin and acid–base status, and on medications. Drugs that block the renin–angiotensin system — ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists — are mainstays of kidney and heart protection but predictably raise potassium. Diabetes, metabolic acidosis, constipation, and high-potassium diets or salt substitutes add risk. Because hyperkalemia is usually silent until it affects the heart, scheduled blood monitoring, not symptoms, is what keeps patients safe.

The current landscape

The treatment landscape has shifted from simply stopping protective medicines to actively managing potassium so those medicines can continue. Correcting metabolic acidosis with alkali therapy helps shift potassium back into cells and supports kidney health. Loop diuretics increase potassium excretion in patients who still make urine. The most significant change is the arrival of modern gastrointestinal potassium binders — patiromer and sodium zirconium cyclosilicate — which trap potassium in the gut and are designed for long-term use, unlike older resins that were poorly tolerated. Trials of these agents have focused on enabling patients to stay on renin–angiotensin system inhibitors at effective doses.

In practice

Monitoring frequency follows CKD stage and medication changes: potassium is rechecked after starting or increasing a renin–angiotensin blocker or diuretic, and at intervals matched to risk. Dietary counselling is individualised — blanket potassium restriction is discouraged because it can remove heart-healthy foods; dietitians target the biggest sources, processed-food additives, and salt substitutes instead. Medication review looks for trimethoprim, NSAIDs, potassium supplements, and herbal products. Before treating a high result, pseudohyperkalemia from a hemolysed or mishandled sample is excluded by repeating the test when the clinical picture does not fit.

When to escalate

Severe hyperkalemia is an emergency. A markedly elevated potassium, or any elevation with ECG changes — peaked T waves, widened QRS, loss of P waves — needs immediate hospital treatment to stabilise the heart membrane, shift potassium into cells, and remove it from the body, with dialysis as the definitive route in kidney failure. Patients should be taught the few warning signs that matter — palpitations, fainting, severe muscle weakness — and told that absence of symptoms does not mean a high reading can wait.

Common questions

What level counts as high potassium?

Laboratories set their own reference ranges, but potassium persistently above the normal range — commonly above about 5.0 mmol/L — is classed as hyperkalemia, with higher bands guiding urgency. Any result is interpreted alongside the trend, kidney function, and the ECG.

Do kidney-protective medicines have to stop if potassium rises?

Not automatically. Modern practice first corrects acidosis, adjusts diuretics and diet, and may add a potassium binder, precisely so that ACE inhibitors, ARBs, and related medicines — which slow kidney decline — can be continued where possible. Dose changes are individualised.

Which foods matter most for potassium control?

The largest contributors are usually processed foods with potassium additives, salt substitutes based on potassium chloride, and very large portions of high-potassium staples. Counselling is tailored by a dietitian rather than a blanket ban, because fruits and vegetables carry wider health benefits.

Can a high potassium result be wrong?

Yes. Hemolysis during collection, a tight tourniquet with repeated fist clenching, or delayed processing can falsely raise the measured value — pseudohyperkalemia. When a result does not fit the clinical picture, it is repeated carefully before major treatment decisions.

More in Chronic Kidney Disease Care

Related

Related reading

Sources

This Clinical Update is educational content for clinicians and informed patients. It is not medical advice and does not replace the judgment of the treating team. Drug classes are discussed in general terms only; prescribing decisions, doses, and monitoring belong with the patient's own clinicians. Acute severe hyperkalemia is a medical emergency; this page describes chronic management principles only.